It looked like an over reaction this morning for a company that increased earnings, again.
Resmed is in a hot sector and targets a unique health problem.
Sleep Apnea still remains under-diagnosed which will provide RMD growth for years to come. Imo it could also be a acquisition target by an American health giant given its growth potential and cash flow.
A nice top up opportunity.
It looked like an over reaction this morning for a company that...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.66 |
Change
-0.940(2.50%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $36.32 | $36.69 | $36.13 | $46.16M | 1.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13944 | $36.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.71 | 12610 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
